Actively Recruiting

Age: 18Years +
All Genders
NCT06418698

The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical Thrombectomy

Led by Zhujiang Hospital · Updated on 2025-07-28

434

Participants Needed

1

Research Sites

270 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

CAIS-MT is a single-center, prospective cohort study, to evaluate the correlation between outcomes of endovascular treatment(EVT) and intracranial artery calcification(IAC) in patients with acute ischemic stroke due to large or medium vessel occlusion.

CONDITIONS

Official Title

The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical Thrombectomy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or non-pregnant women with acute stroke symptoms aged over 18 years
  • Occlusion of specified intracranial arteries confirmed by CT, MR angiography, or digital subtraction angiography
  • No absolute contraindication to iodinated contrast media
  • Planned treatment with endovascular treatment by clinical care team
  • Informed consent obtained from patients or their legal representatives
  • Willingness to be followed up as required by the clinical study protocol
Not Eligible

You will not qualify if you...

  • Acute ischemic stroke occurring more than 24 hours after last known well time
  • Neurologic deficits caused by conditions other than ischemic stroke, such as intracerebral hemorrhage, subarachnoid hemorrhage, or intracranial tumors
  • Other underlying factors leading to intracranial artery calcification, including hyperthyroidism, end-stage renal disease, long-term use of Warfarin, chronic vitamin D deficiency or overdose, persistent hypomagnesemia, hypercalcemia, hyperphosphatemia, or high oral calcium intake
  • Lack of non-contrast CT images on admission or significant artifacts in CT images preventing IAC measurement
  • Severe renal insufficiency (estimated glomerular filtration rate < 30 ml/min or serum creatinine > 220 µmol/L)
  • Previous cerebrovascular intervention treatment or craniotomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhujiang Hospital, Southern Medical University

Guangzhou, Guangdong, China, 528400

Actively Recruiting

Loading map...

Research Team

F

Feng Xin, MD

CONTACT

W

Wen Zhuohua, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here